Last reviewed · How we verify
Drug: CKD-391, QD, PO
Drug: CKD-391, QD, PO is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 1 development.
At a glance
| Generic name | Drug: CKD-391, QD, PO |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Drug: CKD-391, QD, PO CI brief — competitive landscape report
- Drug: CKD-391, QD, PO updates RSS · CI watch RSS
- Chong Kun Dang Pharmaceutical portfolio CI
Frequently asked questions about Drug: CKD-391, QD, PO
What is Drug: CKD-391, QD, PO?
Drug: CKD-391, QD, PO is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.
Who makes Drug: CKD-391, QD, PO?
Drug: CKD-391, QD, PO is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).
What development phase is Drug: CKD-391, QD, PO in?
Drug: CKD-391, QD, PO is in Phase 1.
Related
- Manufacturer: Chong Kun Dang Pharmaceutical — full pipeline
- Compare: Drug: CKD-391, QD, PO vs similar drugs
- Pricing: Drug: CKD-391, QD, PO cost, discount & access